EC Number   |
Title |
Organism |
|---|
   2.3.1.17 | Design and optimization of aspartate N-acetyltransferase inhibitors for the potential treatment of Canavan disease |
Homo sapiens |
| 2.3.1.17 | Development of bisubstrate analog inhibitors of aspartate N-acetyltransferase, a critical brain enzyme |
Homo sapiens |
| 2.3.1.17 | N-acetylaspartate pathway is nutrient responsive and coordinates lipid and energy metabolism in brown adipocytes |
Mus musculus |
| 2.3.1.17 | Role of increased N-acetylaspartate levels in cancer |
Homo sapiens |
| 2.3.1.17 | Biosynthesis of N-acetyl-L-aspartic acid |
Rattus norvegicus |
| 2.3.1.17 | Characterization of the N-acetylaspartate biosynthetic enzyme from rat brain |
Rattus norvegicus |
| 2.3.1.17 | Determinants of the enzymatic activity and the subcellular localization of aspartate N-acetyltransferase |
Homo sapiens |
| 2.3.1.17 | Direct determination of the N-acetyl-L-aspartate synthesis rate in the human brain by (13)C MRS and [1-(13)C]glucose infusion |
Homo sapiens |
| 2.3.1.17 | Methamphetamine-induced neuronal protein NAT8L is the NAA biosynthetic enzyme: implications for specialized acetyl coenzyme A metabolism in the CNS |
Mus musculus |
| 2.3.1.17 | Methamphetamine-induced neuronal protein NAT8L is the NAA biosynthetic enzyme: implications for specialized acetyl coenzyme A metabolism in the CNS |
Homo sapiens |
